WHO World Health Raport 2010. Health systems financing: the path to universal coverage. http://www.who.int/whr/2010/en/index.html Ostatni dostęp: 10.02.2013.
Introduction, Generic Medicines: Quality medicines at affordable prices European Generic Medicines Association. http://www.egagenerics.com/index.php/generic-medicines/introduction; Ostatni dostęp: 10.02.2013.
Lewek P, Kardas P. Generic drugs: the benefits and risks of making the switch. J Fam Pract 2010; 59(11): 634–640.
Kesselheim AS , Misono AS , Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease:a systematic review and meta-analysis. JAMA 2008; 300(21): 2514–2526. doi: 10.1001/jama.2008.758.
Rubak SL, et al. How do pharmacists evaluate the newly introduced system of substituting prescription. Ugeskr Laeger 2000;162: 6074–6077.
Allenet B, Barry H. Opinion and behavior of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1000 French community pharmacists. Pharm World Sci 2003; 25:197–202.
Lewek P, Kardas P. Polish doctors’, pharmacists’ and patients’ opinions about generic drugs – results of a survey. J Health Policy, Insurance and Management. Polityka Zdrowotna 2011; VIII /I: 145–152
Babar ZU , Grover P, Stewart J, et al. Evaluating pharmacists‘ views, knowledge, and perception regarding generic medicines in New Zealand. Res Social Adm Pharm 2011; 7(3): 294–305. doi:10.1016/j.sapharm.2010.06.004.
Ustawa o świadczeniach opieki zdrowotnej finansowanych ze środków publicznych (Dz.U. z dnia 27 września 2004 r. nr 210, poz. 2135, Art. 38 i 62 z późn. zm.).